4
Changes in Ownership
Spero Therapeutics, Inc. Filed Acc 0000950170-23-037973
CEO and President acquired 266,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Shukla Sath CEO and President | 2023-08-01 | Grant or award | +266,000 | 578,517 | D |
Loading xslF345X05/ownership.xml…